The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boesteanu, A.
Right arrow Articles by Joyce, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boesteanu, A.
Right arrow Articles by Joyce, S.
The Journal of Immunology, 1998, 161: 4719-4727.
Copyright © 1998 by The American Association of Immunologists

A Molecular Basis for How a Single TCR Interfaces Multiple Ligands1

Alina Boesteanu*, Michael Brehm*, Lawrence M. Mylin*, Gregory J. Christianson{dagger}, Satvir S. Tevethia*, Derry C. Roopenian{dagger} and Sebastian Joyce2,*

* Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033; and {dagger} The Jackson Laboratory, Bar Harbor, ME 04609

CD8+ T cells respond to Ags when their clonotypic receptor, the TCR, recognizes nonself peptides displayed by MHC class I molecules. The TCR/ligand interactions are degenerate because, in its life time, the TCR interacts with self MHC class I-self peptide complexes during ontogeny and with self class I complexed with nonself peptides to initiate Ag-specific responses. Additionally, the same TCR has the potential to interact with nonself class I complexed with nonself peptides. How a single TCR interfaces multiple ligands remains unclear. Combinatorial synthetic peptide libraries provide a powerful tool to elucidate the rules that dictate how a single TCR engages multiple ligands. Such libraries were used to probe the requirements for TCR recognition by cloned CD8+ T cells directed against Ags presented by H-2Kb class I molecules. When H-2Kb contact residues were examined, position 3 of the peptides proved more critical than the dominant carboxyl-terminal anchor residue. Thus, secondary anchor residues can play a dominant role in determining the antigenicity of the epitope presented by class I molecules. When the four solvent-exposed potential TCR contact residues were examined, only one or two of these positions required structurally similar residues. Considerable structural variability was tolerated at the remaining two or three solvent-exposed residues of the Kb-binding peptides. The TCR, therefore, requires close physico-chemical complementarity with only a few amino acid residues, thus explaining why TCR/MHC interactions are of low affinity and degenerate.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Yoshimura, R. Yadav, G. J. Christianson, W. U. Ajayi, D. C. Roopenian, and S. Joyce
Duration of Alloantigen Presentation and Avidity of T Cell Antigen Recognition Correlate with Immunodominance of CTL Response to Minor Histocompatibility Antigens
J. Immunol., June 1, 2004; 172(11): 6666 - 6674.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. H. G. Kessels, K. E. de Visser, F. H. Tirion, M. Coccoris, A. M. Kruisbeek, and T. N. M. Schumacher
The Impact of Self-Tolerance on the Polyclonal CD8+ T Cell Repertoire
J. Immunol., February 15, 2004; 172(4): 2324 - 2331.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yadav, Y. Yoshimura, A. Boesteanu, G. J. Christianson, W. U. Ajayi, R. Shashidharamurthy, A. K. Stanic, D. C. Roopenian, and S. Joyce
The H4b Minor Histocompatibility Antigen Is Caused by a Combination of Genetically Determined and Posttranslational Modifications
J. Immunol., May 15, 2003; 170(10): 5133 - 5142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Brehm, T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh
Direct Visualization of Cross-Reactive Effector and Memory Allo-Specific CD8 T Cells Generated in Response to Viral Infections
J. Immunol., April 15, 2003; 170(8): 4077 - 4086.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. de Visser, T. A. Cordaro, H. W. H. G. Kessels, F. H. Tirion, T. N. M. Schumacher, and A. M. Kruisbeek
Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide Ligands
J. Immunol., October 1, 2001; 167(7): 3818 - 3828.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Joshi, P. R. Suresh, and V. S. Chauhan
Flexibility in MHC and TCR Recognition: Degenerate Specificity at the T Cell Level in the Recognition of Promiscuous Th Epitopes Exhibiting No Primary Sequence Homology
J. Immunol., June 1, 2001; 166(11): 6693 - 6703.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. C. Godthelp, M. J. D. van Tol, J. M. Vossen, and P. J. van den Elsen
Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire
Int. Immunol., April 1, 2001; 13(4): 507 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Regner, M. Lobigs, R. V. Blanden, P. Milburn, and A. Mullbacher
Antiviral Cytotoxic T Cells Cross-Reactively Recognize Disparate Peptide Determinants from Related Viruses but Ignore More Similar Self- and Foreign Determinants
J. Immunol., March 15, 2001; 166(6): 3820 - 3828.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Sandberg, L. Franksson, J. Sundback, J. Michaelsson, M. Petersson, A. Achour, R. P. A. Wallin, N. E. Sherman, T. Bergman, H. Jornvall, et al.
T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity
J. Immunol., July 1, 2000; 165(1): 25 - 33.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.